455 related articles for article (PubMed ID: 21551322)
1. Sarcomere gene mutations in isolated left ventricular noncompaction cardiomyopathy do not predict clinical phenotype.
Probst S; Oechslin E; Schuler P; Greutmann M; Boyé P; Knirsch W; Berger F; Thierfelder L; Jenni R; Klaassen S
Circ Cardiovasc Genet; 2011 Aug; 4(4):367-74. PubMed ID: 21551322
[TBL] [Abstract][Full Text] [Related]
2. Mutations in sarcomere protein genes in left ventricular noncompaction.
Klaassen S; Probst S; Oechslin E; Gerull B; Krings G; Schuler P; Greutmann M; Hürlimann D; Yegitbasi M; Pons L; Gramlich M; Drenckhahn JD; Heuser A; Berger F; Jenni R; Thierfelder L
Circulation; 2008 Jun; 117(22):2893-901. PubMed ID: 18506004
[TBL] [Abstract][Full Text] [Related]
3. Clinical features and outcome of hypertrophic cardiomyopathy associated with triple sarcomere protein gene mutations.
Girolami F; Ho CY; Semsarian C; Baldi M; Will ML; Baldini K; Torricelli F; Yeates L; Cecchi F; Ackerman MJ; Olivotto I
J Am Coll Cardiol; 2010 Apr; 55(14):1444-53. PubMed ID: 20359594
[TBL] [Abstract][Full Text] [Related]
4. The importance of genetic counseling, DNA diagnostics, and cardiologic family screening in left ventricular noncompaction cardiomyopathy.
Hoedemaekers YM; Caliskan K; Michels M; Frohn-Mulder I; van der Smagt JJ; Phefferkorn JE; Wessels MW; ten Cate FJ; Sijbrands EJ; Dooijes D; Majoor-Krakauer DF
Circ Cardiovasc Genet; 2010 Jun; 3(3):232-9. PubMed ID: 20530761
[TBL] [Abstract][Full Text] [Related]
5. Diagnostic yield, interpretation, and clinical utility of mutation screening of sarcomere encoding genes in Danish hypertrophic cardiomyopathy patients and relatives.
Andersen PS; Havndrup O; Hougs L; Sørensen KM; Jensen M; Larsen LA; Hedley P; Thomsen AR; Moolman-Smook J; Christiansen M; Bundgaard H
Hum Mutat; 2009 Mar; 30(3):363-70. PubMed ID: 19035361
[TBL] [Abstract][Full Text] [Related]
6. Sarcomere mutations in cardiogenesis and ventricular noncompaction.
McNally E; Dellefave L
Trends Cardiovasc Med; 2009 Jan; 19(1):17-21. PubMed ID: 19467449
[TBL] [Abstract][Full Text] [Related]
7. Microvascular function is selectively impaired in patients with hypertrophic cardiomyopathy and sarcomere myofilament gene mutations.
Olivotto I; Girolami F; Sciagrà R; Ackerman MJ; Sotgia B; Bos JM; Nistri S; Sgalambro A; Grifoni C; Torricelli F; Camici PG; Cecchi F
J Am Coll Cardiol; 2011 Aug; 58(8):839-48. PubMed ID: 21835320
[TBL] [Abstract][Full Text] [Related]
8. Mutations in the gene for cardiac myosin-binding protein C and late-onset familial hypertrophic cardiomyopathy.
Niimura H; Bachinski LL; Sangwatanaroj S; Watkins H; Chudley AE; McKenna W; Kristinsson A; Roberts R; Sole M; Maron BJ; Seidman JG; Seidman CE
N Engl J Med; 1998 Apr; 338(18):1248-57. PubMed ID: 9562578
[TBL] [Abstract][Full Text] [Related]
9. Prevalence of sarcomere protein gene mutations in preadolescent children with hypertrophic cardiomyopathy.
Kaski JP; Syrris P; Esteban MT; Jenkins S; Pantazis A; Deanfield JE; McKenna WJ; Elliott PM
Circ Cardiovasc Genet; 2009 Oct; 2(5):436-41. PubMed ID: 20031618
[TBL] [Abstract][Full Text] [Related]
10. Left ventricular non-compaction revisited: a distinct phenotype with genetic heterogeneity?
Oechslin E; Jenni R
Eur Heart J; 2011 Jun; 32(12):1446-56. PubMed ID: 21285074
[TBL] [Abstract][Full Text] [Related]
11. A molecular screening strategy based on beta-myosin heavy chain, cardiac myosin binding protein C and troponin T genes in Italian patients with hypertrophic cardiomyopathy.
Girolami F; Olivotto I; Passerini I; Zachara E; Nistri S; Re F; Fantini S; Baldini K; Torricelli F; Cecchi F
J Cardiovasc Med (Hagerstown); 2006 Aug; 7(8):601-7. PubMed ID: 16858239
[TBL] [Abstract][Full Text] [Related]
12. Prevalence, clinical significance, and genetic basis of hypertrophic cardiomyopathy with restrictive phenotype.
Kubo T; Gimeno JR; Bahl A; Steffensen U; Steffensen M; Osman E; Thaman R; Mogensen J; Elliott PM; Doi Y; McKenna WJ
J Am Coll Cardiol; 2007 Jun; 49(25):2419-26. PubMed ID: 17599605
[TBL] [Abstract][Full Text] [Related]
13. Severe familial left ventricular non-compaction cardiomyopathy due to a novel troponin T (TNNT2) mutation.
Luedde M; Ehlermann P; Weichenhan D; Will R; Zeller R; Rupp S; Müller A; Steen H; Ivandic BT; Ulmer HE; Kern M; Katus HA; Frey N
Cardiovasc Res; 2010 Jun; 86(3):452-60. PubMed ID: 20083571
[TBL] [Abstract][Full Text] [Related]
14. Diastolic dysfunction without left ventricular hypertrophy is an early finding in children with hypertrophic cardiomyopathy-causing mutations in the beta-myosin heavy chain, alpha-tropomyosin, and myosin-binding protein C genes.
Poutanen T; Tikanoja T; Jääskeläinen P; Jokinen E; Silvast A; Laakso M; Kuusisto J
Am Heart J; 2006 Mar; 151(3):725.e1-725.e9. PubMed ID: 16504640
[TBL] [Abstract][Full Text] [Related]
15. Mutations in the sarcomere gene MYH7 in Ebstein anomaly.
Postma AV; van Engelen K; van de Meerakker J; Rahman T; Probst S; Baars MJ; Bauer U; Pickardt T; Sperling SR; Berger F; Moorman AF; Mulder BJ; Thierfelder L; Keavney B; Goodship J; Klaassen S
Circ Cardiovasc Genet; 2011 Feb; 4(1):43-50. PubMed ID: 21127202
[TBL] [Abstract][Full Text] [Related]
16. Idiopathic restrictive cardiomyopathy in children is caused by mutations in cardiac sarcomere protein genes.
Kaski JP; Syrris P; Burch M; Tomé-Esteban MT; Fenton M; Christiansen M; Andersen PS; Sebire N; Ashworth M; Deanfield JE; McKenna WJ; Elliott PM
Heart; 2008 Nov; 94(11):1478-84. PubMed ID: 18467357
[TBL] [Abstract][Full Text] [Related]
17. Double heterozygosity for mutations in the beta-myosin heavy chain and in the cardiac myosin binding protein C genes in a family with hypertrophic cardiomyopathy.
Richard P; Isnard R; Carrier L; Dubourg O; Donatien Y; Mathieu B; Bonne G; Gary F; Charron P; Hagege M; Komajda M; Schwartz K; Hainque B
J Med Genet; 1999 Jul; 36(7):542-5. PubMed ID: 10424815
[TBL] [Abstract][Full Text] [Related]
18. [Mutations in genes for sarcomeric proteins].
Kimura A
Nihon Rinsho; 2000 Jan; 58(1):117-22. PubMed ID: 10885298
[TBL] [Abstract][Full Text] [Related]
19. Sarcomere mutations in cardiomyopathy with left ventricular hypertrabeculation.
Dellefave LM; Pytel P; Mewborn S; Mora B; Guris DL; Fedson S; Waggoner D; Moskowitz I; McNally EM
Circ Cardiovasc Genet; 2009 Oct; 2(5):442-9. PubMed ID: 20031619
[TBL] [Abstract][Full Text] [Related]
20. Myosin binding protein C mutations and compound heterozygosity in hypertrophic cardiomyopathy.
Van Driest SL; Vasile VC; Ommen SR; Will ML; Tajik AJ; Gersh BJ; Ackerman MJ
J Am Coll Cardiol; 2004 Nov; 44(9):1903-10. PubMed ID: 15519027
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
